FDA Inspection 784225 — Grifols Diagnostic Solutions, Inc.
The FDA completed an inspection of Grifols Diagnostic Solutions, Inc. on May 24, 2012 in Emeryville, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 24, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Emeryville, CA (United States)